The initiation of coverage by UBS with a Neutral rating suggests that the stock is fairly valued at current levels. The price target of $110 indicates where the analyst believes the stock will trade in the near term. This could influence investor sentiment and potentially impact the stock's price, but the neutral rating suggests no significant upward or downward movement is expected in the short term.